NCT04938505

Brief Summary

Nowadays, breast reconstruction is an integral care after mastectomy in breast cancer patient. With the personalized care, choice a breast reconstructive is an important step involving decisions and mutual accord between patients and their physicians in order to anticipate clinical and psychosocial results. Two main families of breast reconstruction techniques are often performed including advantages and complications impacting health related quality of life. Routine assessment of health related quality of life in patients underwent breast reconstruction could allow to identify factors of satisfaction o be taken into account in the choice of breast reconstruction technique in order to improve practices and quality of life of patients

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 4, 2019

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

June 16, 2021

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 24, 2021

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 4, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

May 4, 2025

Completed
Last Updated

June 24, 2021

Status Verified

June 1, 2021

Enrollment Period

5 years

First QC Date

June 16, 2021

Last Update Submit

June 23, 2021

Conditions

Keywords

Breast Reconstruction

Outcome Measures

Primary Outcomes (1)

  • Health related quality of life scores assessed by Breast Q questionnaire

    12 months after breast reconstruction

Secondary Outcomes (7)

  • Number of anxious and depress participants as assessed by Hospital Anxiety and Depression Scale (HADS)

    12 months after breast reconstruction

  • social support as assessed by Sarason's Social Support Questionnaire 6-item (SSQ6)

    12 months after breast reconstruction

  • level of the precariousness and the disparities of health at breast reconstruction patient by the questionnaire Evaluation of the Precariousness and the Disparities of Health for the Centers of Examination of Health (EPICES)

    12 months after breast reconstruction

  • Health related quality of life scores assessed by Breast Q questionnaire

    24 months after breast reconstruction

  • Health related quality of life scores assessed by Breast Q questionnaire

    36 months after breast reconstruction

  • +2 more secondary outcomes

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patient undergoing breast reconstruction after mastectomy for breast cancer

You may qualify if:

  • Normal Breast Checkup ( Mammography, echography and breast magnetic resonance imaging)in the previous 6 months
  • French speaking and writing fluency
  • Agree to participate after receive all information

You may not qualify if:

  • Patients with an inability to complete HRQOL questionnaires (cognitive disorders, language barrier)
  • Patient with a failed first breast reconstruction

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Georges Francois Leclerc

Dijon, France

RECRUITING

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Clementine JANKOWSKI, MD

    Centre Georges François Leclerc

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sandrine DABAKUYO, PHD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 16, 2021

First Posted

June 24, 2021

Study Start

May 4, 2019

Primary Completion

May 4, 2024

Study Completion

May 4, 2025

Last Updated

June 24, 2021

Record last verified: 2021-06

Locations